Kanabo Group (KNB) Competitors GBX 1 +0.10 (+11.11%) (As of 11/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors KNB vs. TLY, SPI, MGP, SBI, AKR, STX, AOR, POLX, HEMO, and BELLShould you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Akers Biosciences (AKR), Shield Therapeutics (STX), AorTech International (AOR), Polarean Imaging (POLX), Hemogenyx Pharmaceuticals (HEMO), and Belluscura (BELL). These companies are all part of the "medical" sector. Kanabo Group vs. Totally Spire Healthcare Group Medica Group Sourcebio International Akers Biosciences Shield Therapeutics AorTech International Polarean Imaging Hemogenyx Pharmaceuticals Belluscura Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Is TLY or KNB more profitable? Kanabo Group has a net margin of 0.00% compared to Totally's net margin of -2.94%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.Company Net Margins Return on Equity Return on Assets Totally-2.94% -8.85% -2.42% Kanabo Group N/A -83.19%-20.89% Does the MarketBeat Community favor TLY or KNB? Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users. CompanyUnderperformOutperformTotallyOutperform Votes13172.78% Underperform Votes4927.22% Kanabo GroupN/AN/A Does the media prefer TLY or KNB? In the previous week, Totally's average media sentiment score of 0.66 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the media. Company Overall Sentiment Totally Positive Kanabo Group Neutral Do institutionals & insiders hold more shares of TLY or KNB? 51.3% of Totally shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 13.3% of Totally shares are owned by insiders. Comparatively, 37.0% of Kanabo Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher valuation & earnings, TLY or KNB? Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTotally£106.68M0.17-£3.13M-£0.02-451.25Kanabo Group£1.14M4.99-£8.18M-£0.01-90.00 Do analysts recommend TLY or KNB? Totally presently has a consensus price target of GBX 20, suggesting a potential upside of 121.61%. Given Totally's stronger consensus rating and higher probable upside, equities research analysts clearly believe Totally is more favorable than Kanabo Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Totally 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kanabo Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, TLY or KNB? Totally has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, indicating that its share price is 204% more volatile than the S&P 500. SummaryTotally beats Kanabo Group on 10 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Kanabo Group News Delivered to You Automatically Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KNB vs. The Competition Export to ExcelMetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON ExchangeMarket Cap£5.69M£1.32B£4.99B£1.42BDividend YieldN/A3.79%7.68%11.12%P/E Ratio-90.00225.9683.111,572.53Price / Sales4.9961.151,397.68214,314.90Price / Cash1.8212.9433.1633.70Price / Book0.902.244.642.83Net Income-£8.18M£52.03M£117.31M£157.69M7 Day Performance-17.43%0.61%-3.01%3.93%1 Month Performance-18.18%0.04%-4.13%2.44%1 Year Performance-32.08%13.75%30.13%120.33% Kanabo Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KNBKanabo GroupN/AGBX 1+11.1%N/A-32.1%£6.32M£1.14M-90.0020Gap UpTLYTotally3.5337 of 5 starsGBX 9.50+1.2%N/A+27.1%£18.67M£106.68M-475.001,668Gap DownSPISpire Healthcare Group2.961 of 5 starsGBX 218.14-0.6%N/A-4.4%£880.89M£1.44B3,116.29420Gap UpMGPMedica GroupN/AGBX 211flatN/AN/A£259.85M£76.98M3,516.671,212SBISourcebio InternationalN/AGBX 115+4.5%N/AN/A£85.31M£75.61M1,277.78194Gap UpHigh Trading VolumeAKRAkers BiosciencesN/AGBX 57.50flatN/AN/A£21.64M£2.32M-0.44120STXShield TherapeuticsN/AGBX 2.70flatN/A-55.4%£21.12M£21.47M-67.5040,000Gap UpAORAorTech InternationalN/AGBX 123.50-2.4%N/A+0.0%£19.99M£539,000.00-33.383POLXPolarean ImagingN/AGBX 1.53-3.4%N/A-77.4%£18.55M£1.87M-76.6528Gap UpHEMOHemogenyx PharmaceuticalsN/AGBX 1.28+2.6%N/A-45.6%£17.15MN/A-128.0014Gap DownBELLBelluscuraN/AGBX 10.05-2.0%N/A-59.5%£16.93M£1.80M-100.5024Gap Down Related Companies and Tools Related Companies Totally Alternatives Spire Healthcare Group Alternatives Medica Group Alternatives Sourcebio International Alternatives Akers Biosciences Alternatives Shield Therapeutics Alternatives AorTech International Alternatives Polarean Imaging Alternatives Hemogenyx Pharmaceuticals Alternatives Belluscura Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:KNB) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kanabo Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kanabo Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
